Amgen

Open: 257.52 Close: 258.83 Change: 1.32

The 16 top things that an AI found about Amgen Stock... they will surprise you

How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, stock, …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen announces 2023 third quarter dividend for the third quarter of 2023. Amgen announced revenue of $6.99 billion, up 6% from a year earlier, above the FactSet consensus. For the full year, Amgen modestly raised its outlook.

Today's News

Amgen Inc. raised 2023 adj. adj. revenue, above FactSet consensus $6.66 bln. Q2 revenue up 6% to $6.99 bln, above the FactSet. consensus. Amgen raises full-year outlook. Amgen announces 2023 third quarter dividend for the third quarter of 2023. Amgen is one of the largest biotechnology companies in the world, with a presence in dozens of countries. Amgen reported revenue of $6.99 billion, up 6% from a year earlier. Product sales by volume grew 11% from year earlier, but net selling prices fell 2%, while foreign exchange rates and lower inventory levels limited revenue gains. For the full year, Amgen modestly raised its outlook for adjusted earnings. Amgen Inc.s (AMGN) dividend yield is 3.37%, which means that for every $100 invested in the company, investors would receive $3.37 in dividends per year. Amgens payout ratio is 54.57%. The companys ex-dividend date is August 17, 2023. Manager, New Product Strategy role at Amgen Thousand Oaks, CA. is $118,774- $165,765. Director, Contracts and Pricing Execution (US Remote) Director, Corporate Affairs, Enterprise Media (US - Remote) Amgen Inc.s market capitalization is $130.01 B by 534.33 M shares outstanding. Amgen stock has received a consensus rating of hold. The 61 analysts offering price forecasts for Amgen have a median target of 249.80. The high in the last 52 weeks of Amgen has been 296.63. Amgen is committed to the discovery and development of precision medicine on precision medicine. RBC Capital Markets Maintained Hold $253 neutral 07/25/23 Oppenheimer & Co. Amgen Inc. raised 2023 profit, sales guidance even as key drugs falter. New medicines Amjevita and Lumakras missed expectations. The main benchmarks closed higher ahead of this weeks key inflation update. Dow Outperforms as Amgen, Boeing Gain Ground. Amgen Inc. (AMGN) Up 5.74% to $243.94 after Earnings Beat InvestorsObserver - 3 days ago. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. Q3 earnings are confirmed for Thursday, November 2, 2023. Q2 earnings for Amgen are scheduled for November 2. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. There is no upcoming split for Amgen. Amgen (AMGN) is in the Health Care sector and Biotechnology industry. The stock price for Amgen is $ 262.005 last updated today at August 8, 2023 at 2:04 PM UTC. Amgens Q3 earnings are confirmed for Thursday, November 2, 20 23. Amgen (AMGN) stock price for Amgen is $ 262.005 last updated Today at August 8, 2023 at 2:04 PM UTC. Amgens Q3 earnings are confirmed for Thursday, November 2, 20 23. There is no upcoming split. Amgen (AMGN) stock price for Amgen stock is 262,005 at 2:04 PM UTC. Shareholders of Amgen Inc. are advised to contact the Portnoy Law Firm. Amgen Stock (NASDAQ:AMGN), Quotes and News Summary Amgen stock price, news, charts, charts and stock research. Amgen (NASDAQ:AMGN) stock price is $ 262.005 last updated Today at August 8, 2023 at 2:04 PM UTC. Amgen is in the Health Care sector and Biotechnology. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. There is no upcoming split for Amgen. Amgen (AMGN) is in the Health Care sector and Biotechnology industry. The stock price for Amgen is $ 262.005 last updated today at August 8, 2023 at 2:04 PM UTC. Amgens Q3 earnings are confirmed for Thursday, November 2, 20 23. Amgen (AMGN) Receives a Sell from Robert W. Baird TipRanks - 5 hours ago Amgen is in the Health Care sector and Biotechnology industry. Amgens Q3 earnings are confirmed for November 2, 2023. Amgen Senior Engineer, Process Development (Downstream) in Holly Springs, North Carolina. Be part of Amgens newest drug substance manufacturing plant. Engineer will be part of the Process Development-Drug Substance Technology at Amgens FleX Batch facility, focusing on technology transfer, process support, and optimization.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, stock, price, earnings, AMGN, Amgens, Health, and the most common words in the summary are: amgen, stock, inc, job, market, best, amgn, . One of the sentences in the summary was: For the full year, Amgen modestly raised its outlook.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #inc #job #market #best #amgn.